michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Thanks, Laurence, for the question. As Mark sized it earlier, we started with a goal of delivering a flat cost structure in 2021, and that was on top of reducing our cost by roughly $150 million compared to 2019. And as we look forward, we look to continue to grow that, and we see another $50-plus million over the next year plus. Also, what we're trying to do there, Laurence, is that frees up capacity as we create the incremental gains to continue to fund our growth without substantially growing our cost structure. So that's the way I would frame it at this point. And we continue to also look at leveraging assets and sites, etc, to continue to gain better fixed cost leverage where we have additional capabilities as we've highlighted previously.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think as we said some moments ago, the demand is -- remains very strong. Chemical price inflation has continued through the end of the year. It looks like it will continue into 2022. And we're really hitting our operational stride. And so I think those things give us more confidence about the numbers that we will achieve in 2022 and beyond.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good morning, Mitra. Yes, there's four core areas that we think as an outpatient provider that primarily as we see a shift to population health would be beneficial not just for the company but hopefully for the populace. If you look at the various cancers that are most significant in volume you deal with breast cancer, prostate cancer, lung cancer and colon cancer those that come for about 80% of all of the cancers and each of those have screening tools that exist right now that I believe can be demonstrably improved through application of artificial intelligence. We've already demonstrated some of that and have indeed put our capital to work as regards to mammography.
So once we get some good traction on that, we plan and are already looking at some initiatives for at least prostate along with colon and lung cancers down the road. We think if anything that concerned as a great tool for putting some definition behind what population health needs, we believe that diagnostic imaging will be at the forefront of that and that tools in these areas can have a very prominent effect on both diagnosing earlier as well as and obviously leading to lower cost and reduced mortality. So we think it's incumbent upon us as the leader in this industry as well as just generally what's good for the population to focus our attention on these tools and provide programs for the insurers, health insurers as well as employers to give some real new definition to population health.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'll start with that, Michael, this is Willie. What we've always talked about our system being able to have access to multiple markets. There's so much that goes on in market dynamics that it's nice to have the flexibility to go to both. I think it'd be difficult for us to give you exit rates to each market as it sits today because there's just too many variables that are out there.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
That's correct. My word was...

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, guys, thanks for taking the questions. Just a couple of quick ones. Sorry, if they were asked already. I've been jumping around a couple of calls.
So Pedro, can you talk about how big the first-party business was on e-commerce during 1Q? And then, where do you expect it to reach for the rest of the year? Is the margin profile of 1P kind of at a place where you want it to be? Or is there opportunities to improve that as well? And then, the second question. Can you provide some color on April trends on e-commerce? Obviously, the COVID situation in LatAm is very volatile. But what are you seeing in terms of kind of relative consumer behavior, maybe in countries where vaccination rates are over-indexing with respect to the average? Thank you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
At some point in time, you would have to dispose. So they can be incinerated or they can put and be put into a landfill. Again, we're working with a lot of the landfill operators to understand their needs and requirements. But yes, you would have to dispose it. It can be also used -- I know part of your question was whether it can be used in combination with other materials? Yes, it can. And so, we find that there are some applications where they may have large volume, and they use one filtration medium first and then they really get the effective absorption through the FLUORO-SORB. So, a variety of different ways it can be used.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good afternoon, Peter. Good afternoon, Roger. Thanks for taking the question. I wanted to come back to the point you were making around DUV capacity. In particular, for this year, just to try and establish a baseline, can you give us a sense as to how much of the -- this year's revenue is being driven by the buffer stocks, sort of the drawdown of that inventory that you've got?
If I'm doing my math right, based on your guidance, we're now talking about a low EUR8 billion level of DUV revenue this year. So, yeah, how much of that's coming from the inventory?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Peter said -- do you have the number? I think I saw the number was 18% for eco-friendly products.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, you're right. And we remain long term bullish on the Brazilian market and I've said in the past. If we look at the Brazilian -- our Brazilian Experience since 1996 when we entered the market in beverage cans and if you want to cut that into five-year increments or three-year increments. Sure, in any three-month or six-month period you may see a decline relative to the prior three-month or six-month period. But if you want to start cutting this up in two-year or three-year or five-year increments, we've experienced nothing other than tremendous growth over any increments like that.
And as I said in the prepared remarks, while we've experienced slowdowns for a variety of reasons in the past, whether it's the marketing efforts of our customers vis-a-vis the can versus other packaging substrates and or consumer pullback, which there is a mild consumer pull back right now, we've always recovered to even higher levels and we would expect that the market will continue to recover to higher levels as we look forward. We're obviously entering their strongest period right now, late fourth quarter, first quarter and and we're bullish on the prospects for high sales through the high season here.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, good morning. Erik, thank you for all the color around the accrued expenses piece. Just a quick follow-up or two on that. One is it looks like it's $550 million you're talking about in the second half of the year.
And that number sounds consistent with the last quarter call, I believe, so I guess should I just infer that in the second quarter -- I think there was an initial plan to maybe pay some of that in the second quarter. It was just pushed to the second half. And then related to that I guess what you're implying is that about $500 million of the RINs is for 2021? Just wanted to confirm that number.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. It's a tough question. I think that as we begin comping the COVID surge, I think it will be interesting to see how everybody across the food landscape reacts, and whether there becomes pressure to try to accelerate that volume and be aggressive on pricing or just recognize it, that's going to be a tough comp to measure against. So, I don't particularly worry too much about specifically what happens in the back half relative to our prior year. We're looking at the back half relative to the performance in the first half, which is what we've been trying to benchmark against, so that we can see that the overall business is getting back to where we expect it to be.
I think the question that we spend more time on is following the totality of this two-year period, what has the experiment and all this trial meant to the long-term growth rate of these categories? And our assumption is that it's a positive number, whether that's positive one or positive three, I think there's an element of putting your finger in the wind. But we think it's a positive number and has implications on how we think about innovation, capacity management, and well beyond.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. So, we have already started a clinical trial with boosting participants who had received two doses of our vaccine. And this will -- at the end of the day, it is more or less an automatic approach based on understanding of titers, protection and the level of improvement that can be accomplished by a booster dose.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Operator, we'll take one more question. Thanks.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No. So it is getting a little bit better. I just -- it's a battle.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, thank you. Casey and thank you everyone for joining us. This is a very exciting time for our company and a very important transition year for us and we appreciate you turning in and look forward to updating you on our first quarter results. Have a great day.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. It's definitely getting better. And we -- as we indicated at the end of Q2, we had a substantial number of deals that fell from Q2 into Q3. As Stacey may have indicated, we gained ground on these deals in Q3, closing the majority of those deals.
The good thing is that more deals also enter the funnel, so we're definitely gaining ground. And one of the reasons we're gaining ground on this cycle is that we put in place, in Q2, a sales organization specifically geared toward these enterprise customers. It used to be that reps were allocated on a regional basis. Now we have several reps that are allocated specifically for the enterprise customers, and they can work with them without being at the expense of some of the other deals they may be working on in a quarter.
So we're definitely gaining ground on this, and I think we are going to catch up with this within the next one to two quarters, as we're fully -- and that will include this quarter. And again, the funnel continues to grow, but these enterprise deals, which are roughly around 30% of our deals that will probably grow to about 35% next year -- we're very well positioned at this point in time to be able to gain traction on the remaining deals and those that will emerge.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. Well, first, we operate in states where non-compete don't even affect what we do and we operate very effectively there. So we believe that the best way to operate for any company is to be the employer of choice, as I said before, and we think that people really love working with MEDNAX, and we want to do everything we can to strengthen that. and it works both ways with -- in the absence of not compete. It could enable us to recruit in ways that we think we can today. So I don't see it as a net negative. It's just another reminder that we should operate. And in my past, I've always operated the same.
We want our team to stay here because they love it here not because they're shackled here. So that's how we'll operate. So It's just another reminder to all of us that we have to be the best we possibly can be and be as open in an organization. And I hope you don't think I'm stretching too far by saying it's another reason that focus pays off because all we talk about. There's a reason that Mack spoke for quite a while today because all we talk about is how we take care of women and children and how we take care of our clinicians and how we build a better network, and we think people will want to come here or more.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, I think in coming quarters we'll continue to see you know the full effect of the -- of our increases. I think year on year if I was looking forward to 2022, I'd expect price to be up over $100 million in that set.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. So I mean, I think there is a very much more robust structure that we're in now. We've worked with both of these companies for a very long time, and it's been a pleasure to work with them. They've got some outstanding folks there, and this is a formalization of that in a more organized structure.
And so when you think about being named the preferred supplier in both of these environments and the sheer number of products on our menu and volume across the world, it's very different from being referred to as participating in a test in Canada or some of the Nordic countries. So it is very different in kind in my view.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Hi, Good morning. My first question on retrans subs. Last quarter, I believe you said it was down year-over-year in the low 5s. And I think you said the trends are stable. So I assume that means down roughly 5% in the second quarter year-over-year.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, so that it's not miss characterizing and this may be. I'm assuming this question is coming from the Acme acquisition. We're not necessarily buying those assets to rerent them. We do rerent every once in a while, and we do rerent for people every once in a while. But this was really us buying these assets because they were available and they really fit into our profile of the customers in the projects that we serve.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
You know what to let us work on that, Toby? Yes, we have those metrics internally. But But why don't you let us come back to you with an something that we think would be meaningful, externally for you? We will take that as an action item.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
That's exactly what it's planned for, Jason. We spent 2020 trying to get a lot of projects designed, get the right teams around them, work them through the regulatory agencies. I'll be honest, the Department of Interior suspension was just a touch of a blip. The State of New Mexico Regulatory agencies because we're helping them fulfill their legislative agenda.
I think we'll get everything accomplished that we want to. So, we really look forward to being able to share with the market, the things that we're doing and creating a lot more transparency. I think had COVID had not gone into the first quarter. Where we are.
We'd be having that investor day in this quarter, but COVID is what it is. And so, we're finding certain regulatory agencies. Court systems, legislative bodies are all still operating virtually, and it still slows things down. So, that's just a reality of life that we're dealing with.
It is improving week to week. In terms of being able to get things done either legislatively or regulatory-wise. So, I hope I'm answering your question that we know the market is really wanting a lot more transparency. And we have every intention of getting it as quickly as we can, ensuring the nature of the projects that are ongoing.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, John, Mark. Thanks for taking the questions. I guess, first, just on the updated revenue guidance. Can you just give us a better sense of how you're getting to the top and bottom end of the guidance range, just given that we are having variants increase? You're talking about a return to normal as we move into the back half of the year.
And I'd also be curious if you're seeing any of the surgeon vacation dynamic that other orthopedic or spine companies have been mentioning through earnings so far? Thank you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, I'd like to thank everybody for joining us this afternoon. We tremendously appreciate your support. If you have any further questions, please don't hesitate to contact us, and have a great evening. Thank you for your time.

    Prediction (one of UP, DOWN, SAME): DOWN